Opportunities and Challenges for Environmental Exposure Assessment in Population-Based Studies
- PMID: 28710076
- PMCID: PMC5581729
- DOI: 10.1158/1055-9965.EPI-17-0459
Opportunities and Challenges for Environmental Exposure Assessment in Population-Based Studies
Abstract
A growing number and increasing diversity of factors are available for epidemiological studies. These measures provide new avenues for discovery and prevention, yet they also raise many challenges for adoption in epidemiological investigations. Here, we evaluate 1) designs to investigate diseases that consider heterogeneous and multidimensional indicators of exposure and behavior, 2) the implementation of numerous methods to capture indicators of exposure, and 3) the analytical methods required for discovery and validation. We find that case-control studies have provided insights into genetic susceptibility but are insufficient for characterizing complex effects of environmental factors on disease development. Prospective and two-phase designs are required but must balance extended data collection with follow-up of study participants. We discuss innovations in assessments including the microbiome; mass spectrometry and metabolomics; behavioral assessment; dietary, physical activity, and occupational exposure assessment; air pollution monitoring; and global positioning and individual sensors. We claim the the availability of extensive correlated data raises new challenges in disentangling specific exposures that influence cancer risk from among extensive and often correlated exposures. In conclusion, new high-dimensional exposure assessments offer many new opportunities for environmental assessment in cancer development. Cancer Epidemiol Biomarkers Prev; 26(9); 1370-80. ©2017 AACR.
©2017 American Association for Cancer Research.
References
-
- Wild CP. Complementing the genome with an “exposome”: the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev. 2005;14:1847–50. - PubMed
Publication types
MeSH terms
Grants and funding
- U24 OD023382/OD/NIH HHS/United States
- P30 ES007048/ES/NIEHS NIH HHS/United States
- R01 CA186566/CA/NCI NIH HHS/United States
- U19 CA203654/CA/NCI NIH HHS/United States
- U01 DD000746/DD/NCBDD CDC HHS/United States
- R00 ES023504/ES/NIEHS NIH HHS/United States
- AS7659/AS/Autism Speaks/United States
- R21 ES025052/ES/NIEHS NIH HHS/United States
- R01 CA095586/CA/NCI NIH HHS/United States
- P30 ES013508/ES/NIEHS NIH HHS/United States
- R01 ES015211/ES/NIEHS NIH HHS/United States
- UG3 OD023275/OD/NIH HHS/United States
- P01 CA196569/CA/NCI NIH HHS/United States
- U10 DD000183/DD/NCBDD CDC HHS/United States
- P20 GM104416/GM/NIGMS NIH HHS/United States
- U19 CA148127/CA/NCI NIH HHS/United States
- P20 GM103534/GM/NIGMS NIH HHS/United States
- U2C ES026555/ES/NIEHS NIH HHS/United States
- R01 ES025216/ES/NIEHS NIH HHS/United States
- R01 AI127250/AI/NIAID NIH HHS/United States
- P30 CA023108/CA/NCI NIH HHS/United States
- R01 AG042187/AG/NIA NIH HHS/United States
- P20 ES018175/ES/NIEHS NIH HHS/United States
- P42 ES023720/ES/NIEHS NIH HHS/United States
- R21 CA191651/CA/NCI NIH HHS/United States
- P01 ES022832/ES/NIEHS NIH HHS/United States
- P30 CA016520/CA/NCI NIH HHS/United States
- U01 DD001214/DD/NCBDD CDC HHS/United States
- U01 CA196386/CA/NCI NIH HHS/United States
- R01 ES025531/ES/NIEHS NIH HHS/United States
- R01 CA091016/CA/NCI NIH HHS/United States
- R21 ES025573/ES/NIEHS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
